CLINICAL_TRIALS
trial_result
· 2016-02-22
Clinical Trial Update: Surveillance of Kaletra in Korean Patients
Summary
A completed surveillance study evaluated Kaletra (lopinavir/ritonavir) in Korean patients with HIV-1 infection; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: HIV-1 Infection | Status: COMPLETED | Results posted: 2016-02-22